Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on N aryl Amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel visible light method synthesizes 3-sulfonyl spirocyclic trienones using air oxidant. Reduces energy and metal waste for reliable pharmaceutical intermediate supply chains.
Patent CN102666527B details high-yield synthesis for kinase inhibitors. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical intermediates.
Patent CN113861086A details a novel Pd-catalyzed route for sulfur-containing diarylamine butyramides, offering mild conditions and simplified purification for pharmaceutical supply chains.
Patent CN112961116B reveals a green ultrasound-assisted method for synthesizing high-purity benzoxazole intermediates using recyclable deep eutectic solvents.
Patent CN112047925B details a copper-catalyzed oxidative amination route for N-(aryl/heteroaryl) alkyl-diamides, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN112047879B details a novel copper-catalyzed method for selective halogenation, offering cost-effective and scalable solutions for API intermediate manufacturing.
Patent CN112125843B reveals a green Oxone-mediated route for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN107628964B reveals mild carbonylation for N-aryl benzamides. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN107628964B enables mild carbonylation. Reduces cost and improves supply chain for pharma intermediates. High purity and scalable production.
Patent CN112125843B details a green, metal-free synthesis of 3-hydroxymethyl-4-phenyl-3,4-dihydroquinolinones using Oxone. Discover cost-effective manufacturing strategies for high-purity pharmaceutical intermediates.
Patent CN112125843B reveals a metal-free Oxone-mediated route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN112125843B reveals a metal-free Oxone-mediated route for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Patent CN107628964B enables mild carbonylation for high-purity API intermediates. Reduces cost in fine chemical manufacturing with scalable Pd-catalyzed routes.
Patent CN108912076A details Pd-catalyzed synthesis offering high yield and regioselectivity for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN108148070B details a novel Rh-catalyzed one-pot synthesis of furanone isoquinolinones, offering mild conditions and high efficiency for pharmaceutical intermediate manufacturing.
Efficient carbonylation method for N-aryl amides using aryl boronic acids. Reduces harsh conditions, offering cost-effective manufacturing for pharmaceutical intermediates.
Patent CN113861086B enables high-yield synthesis of complex intermediates with simplified process and reduced environmental impact, ensuring reliable pharmaceutical supply chains.
Solve pyrrole synthesis challenges with 82% yield, mild conditions, and flexible aryl substitution for pharmaceutical intermediates. Reduce supply chain risks now.
Solve supply chain risks with mild, high-yield synthesis of furanone-isoquinolinone compounds for agrochemicals (148 chars)